EA200300028A1 - Лечение и профилактика состояний, ассоциированных с сердечной инсулинорезистентностью - Google Patents
Лечение и профилактика состояний, ассоциированных с сердечной инсулинорезистентностьюInfo
- Publication number
- EA200300028A1 EA200300028A1 EA200300028A EA200300028A EA200300028A1 EA 200300028 A1 EA200300028 A1 EA 200300028A1 EA 200300028 A EA200300028 A EA 200300028A EA 200300028 A EA200300028 A EA 200300028A EA 200300028 A1 EA200300028 A1 EA 200300028A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- insulin resistance
- conditions associated
- prevention
- treatment
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Описан способ лечения и/или профилактики сердечной инсулинорезистентности или состояний, ассоциированных с сердечной инсулинорезистентностью, у человека или млекопитающих, не относящихся к человеку, включающий введение эффективного нетоксичного и фармацевтически приемлемого количества агониста PPARγ, такого как соединение (I) или его фармацевтически приемлемого производного. Состояниями, ассоциированными с сердечной инсулинорезистентностью, являются микроваскулярная стенокардия, атеросклероз и застойная сердечная недостаточность. Указанными соединениями являются розиглитазон, троглитазон, энглитазон и пиоглитазон.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2000/002347 WO2001095906A1 (en) | 2000-06-16 | 2000-06-16 | Treatment and prevention of cardiac insulin resistance associated conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300028A1 true EA200300028A1 (ru) | 2003-04-24 |
Family
ID=9884792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300028A EA200300028A1 (ru) | 2000-06-16 | 2000-06-16 | Лечение и профилактика состояний, ассоциированных с сердечной инсулинорезистентностью |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1292301A1 (ru) |
JP (1) | JP2004503499A (ru) |
CN (1) | CN1592620A (ru) |
AP (1) | AP2002002688A0 (ru) |
BG (1) | BG107384A (ru) |
BR (1) | BR0017254A (ru) |
CA (1) | CA2436116A1 (ru) |
DZ (1) | DZ3389A1 (ru) |
EA (1) | EA200300028A1 (ru) |
HU (1) | HUP0301103A2 (ru) |
IL (1) | IL153452A0 (ru) |
MX (1) | MXPA02012619A (ru) |
NO (1) | NO20026000L (ru) |
WO (1) | WO2001095906A1 (ru) |
YU (1) | YU1203A (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5902726A (en) * | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
AU4050797A (en) * | 1996-08-02 | 1998-02-25 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
WO1999059586A1 (en) * | 1998-05-19 | 1999-11-25 | Regents Of The University Of California | Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis |
MA26662A1 (fr) * | 1998-07-21 | 2004-12-20 | Smithkline Beecham Plc | Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation |
-
2000
- 2000-06-16 CA CA002436116A patent/CA2436116A1/en not_active Abandoned
- 2000-06-16 DZ DZ003389A patent/DZ3389A1/xx active
- 2000-06-16 IL IL15345200A patent/IL153452A0/xx unknown
- 2000-06-16 MX MXPA02012619A patent/MXPA02012619A/es unknown
- 2000-06-16 HU HU0301103A patent/HUP0301103A2/hu unknown
- 2000-06-16 AP APAP/P/2002/002688A patent/AP2002002688A0/en unknown
- 2000-06-16 JP JP2002510084A patent/JP2004503499A/ja active Pending
- 2000-06-16 YU YU1203A patent/YU1203A/sh unknown
- 2000-06-16 EP EP00938933A patent/EP1292301A1/en not_active Withdrawn
- 2000-06-16 BR BR0017254-5A patent/BR0017254A/pt not_active IP Right Cessation
- 2000-06-16 WO PCT/GB2000/002347 patent/WO2001095906A1/en not_active Application Discontinuation
- 2000-06-16 EA EA200300028A patent/EA200300028A1/ru unknown
- 2000-06-16 CN CNA008197679A patent/CN1592620A/zh active Pending
-
2002
- 2002-12-12 BG BG107384A patent/BG107384A/bg unknown
- 2002-12-13 NO NO20026000A patent/NO20026000L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA02012619A (es) | 2003-04-10 |
IL153452A0 (en) | 2003-07-06 |
NO20026000L (no) | 2003-02-11 |
HUP0301103A2 (hu) | 2003-08-28 |
AP2002002688A0 (en) | 2002-12-31 |
WO2001095906A1 (en) | 2001-12-20 |
EP1292301A1 (en) | 2003-03-19 |
BG107384A (bg) | 2003-09-30 |
BR0017254A (pt) | 2004-01-06 |
CN1592620A (zh) | 2005-03-09 |
NO20026000D0 (no) | 2002-12-13 |
YU1203A (sh) | 2006-05-25 |
JP2004503499A (ja) | 2004-02-05 |
CA2436116A1 (en) | 2001-12-20 |
DZ3389A1 (fr) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199800626A1 (ru) | Применение агониста ppar-гамма для лечения синдрома х | |
DOP2004001052A (es) | Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1 | |
WO2004018419A3 (en) | Benzimidazole quinolinones and uses thereof | |
AR093609A2 (es) | Compuesto amorfo de benzimidazol, composicion farmaceutica que lo comprende y metodo para tratar o prevenir la ulcera gastrica | |
WO2005034952A3 (en) | Isoxazole and isothiazole compounds useful in the treatment of inflammation | |
NL300282I1 (nl) | Nieuwe exendineagonistformuleringen en werkwijze voor toediening daarvan. | |
EA200400305A1 (ru) | 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность | |
EA200401160A1 (ru) | Производные тиазола и оксазола, которые модулируют активность ppar | |
EA200300265A1 (ru) | Производные хиназолина в качестве ингибиторов киназы | |
CR11037A (es) | Derivados de 4-tetrazolil -4fenilpiperidina para tratar el dolor (divisional) | |
ATE369845T1 (de) | Behandlung der nebenwirkungen von statinen | |
EA200200097A1 (ru) | Имидазоимидазолы и триазолы в качестве противовоспалительных агентов | |
ATE464905T1 (de) | Phosphattransporthemmer | |
WO2001052847A8 (en) | Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging | |
WO2005030766A8 (en) | Phenyl - carboxamide compounds useful for treating pain | |
KR870007204A (ko) | 작용화 펩티딜 아미노디올 및-트리올 | |
AU2001285807A1 (en) | Acidic treatment liquid and method of treating copper surfaces | |
BR0101090A (pt) | Composição para administração parenteral, e, método para prevenção ou tratamento de infecções ou infestações por helmintos, acarìdeos ou artrópodo endo- ou ectoparasìticos em um animal de sangue quente | |
SE9803760D0 (sv) | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel | |
EA199800139A1 (ru) | Способ лечения аденомы толстой кишки | |
EA200300028A1 (ru) | Лечение и профилактика состояний, ассоциированных с сердечной инсулинорезистентностью | |
Gillen et al. | Problems associated with the clinical use of proton pump inhibitors | |
MX9805512A (es) | Un aparato para colocacion de escuadra en salientes de conducto de ventilacion. | |
NO20000230L (no) | Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor | |
NO971743L (no) | Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer |